Relay Therapeutics, Inc. logo

Relay Therapeutics, Inc.

NASDAQ:RLAY

Overview | Financials
Company Name Relay Therapeutics, Inc.
Symbol RLAY
Currency USD
Price 7.86
Market Cap 1,276,943,460
Dividend Yield 0%
52-week-range 5.7 - 12.14
Industry Biotechnology
Sector Healthcare
CEO Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS
Website https://www.relaytx.com

An error occurred while fetching data.

About Relay Therapeutics, Inc.

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhibitor of fibroblast growth

Related Stocks

Definitive Healthcare Corp. logo

Definitive Healthcare Corp.

DH

4.81 USD

Bright Green Corporation logo

Bright Green Corporation

BGXX

0.148 USD

Amphastar Pharmaceuticals, Inc. logo

Amphastar Pharmaceuticals, Inc.

AMPH

50.09 USD

LumiraDx Limited logo

LumiraDx Limited

LMDX

0.016 USD

Schrödinger, Inc. logo

Schrödinger, Inc.

SDGR

20.84 USD

PROCEPT BioRobotics Corporation logo

PROCEPT BioRobotics Corporation

PRCT

82.79 USD

Myriad Genetics, Inc. logo

Myriad Genetics, Inc.

MYGN

28.29 USD

Ironwood Pharmaceuticals, Inc. logo

Ironwood Pharmaceuticals, Inc.

IRWD

4.51 USD

Financials

Numbers are in millions USD

Numbers are in millions USD